Gara Jalqabaatti › Scleroderma › Texas › Houston
Qorannoo klinikaalii Scleroderma Houston, TX keessatti
Qorannoo 9 Scleroderma f Houston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Namoota walitti qabaa jiraSadarkaa 3
- The University of Texas Health Science Center at Houston, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
- UT MD Anderson Cancer Center, Houston
Platform Clinical Study for Conquering Scleroderma
Namoota walitti qabaa jiraSadarkaa 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Namoota walitti qabaa jiraSadarkaa 1/2
- Nkarta Investigational Site, Houston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Namoota walitti qabaa jiraSadarkaa 2
- Artiva Investigational Site Bellaire, Bellaire · Miili 7 fagaatti
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
Namoota walitti qabaa jiraSadarkaa 2
- The University of Texas Health Science Center at Houston, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Namoota walitti qabaa jiraSadarkaa 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
Namoota walitti qabaa jira
- The University of Texas Health Science Center at Houston, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Namoota walitti qabaa jiraSadarkaa 2
- aTyr Investigative Site, Houston
Qorannoo Scleroderma magaalota biroo keessatti
- New York City, NYQorannoo 11
- Ann Arbor, MIQorannoo 10
- Chicago, ILQorannoo 10
- Boston, MAQorannoo 7
- Durham, NCQorannoo 7
- Los Angeles, CAQorannoo 7
- New Orleans, LAQorannoo 6
- Philadelphia, PAQorannoo 6
- Baltimore, MDQorannoo 6
- Dallas, TXQorannoo 5
- Pittsburgh, PAQorannoo 5
- Plantation, FLQorannoo 4
Qorannoo biroo Houston keessatti
- Kansara Qara'a Non-Small CellQorannoo 145
- Saree OljooQorannoo 126
- Saree (Gosoota Hunda)Qorannoo 121
- Kansara MetastatikiiQorannoo 104
- Kansarii ColorectalQorannoo 102
- Kansarii OvariiQorannoo 89
- Leukemia Myeloidii HamaaQorannoo 85
- Dhibee QaraQorannoo 78
- Kansarii ProstateQorannoo 76
- Kansa EndometiriyaaliiQorannoo 68
- Kansarii PancreasQorannoo 61
- MelanomaQorannoo 59
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.